Science & Programs

Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners.

  • Apabetalone

    The world leader in a new class of drugs designed to regulate disease-associated epigenetics.

  • Clinical Trials

    BETonMACE – a global Phase 3 clinical trial with the most advanced epigenetic drug outside of oncology.

  • Partnership Strategy

    Providing novel science, clinical and value-based health solutions to key stakeholders, including payer groups.